Search results
Results from the WOW.Com Content Network
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
Pharmaceutical compound mRNA-1283 Vaccine description Target SARS-CoV-2 Vaccine type mRNA Clinical data Trade names Spikevax Routes of administration Intramuscular Part of a series on the COVID-19 pandemic Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom. COVID-19 (disease) SARS-CoV-2 (virus) Cases Deaths Timeline 2019 2020 January responses ...
Reducing the risk of long COVID includes staying up to date on the most recent COVID-19 vaccine, practicing good hygiene, maintaining clean indoor air, and physical distancing from people infected with a respiratory virus. [20] The Omicron variant became dominant in the U.S. in December 2021. Symptoms with the Omicron variant are less severe ...
Moderna has a new COVID-19 booster vaccine that targets Omicron and protects against both the original virus and Omicron strains. It was just authorized by officials in the U.K.
Moderna said Monday that a booster dose of its COVID-19 vaccine should offer protection against the rapidly spreading omicron variant. Moderna said lab tests showed the half-dose booster shot ...
The FDA and CDC have approved new bivalent vaccines by Pfizer and Moderna that target both the original strain of COVID-19 and Omicron subvariants.
In Com-COV2, the first dose is the Oxford–AstraZeneca vaccine or the Pfizer vaccine, and the second dose is the Moderna vaccine, the Novavax vaccine, or a homologous vaccine equal to the first dose, with an interval of 56 or 84 days between doses.
Monica Lopez, a nurse at Children's Hospital Los Angeles, prepares to administer the Pfizer/BioNTech COVID-19 vaccine to 3-year-old Callum Diaz-Cheng during the hospital's first round of vaccines ...